ro 48-8071 has been researched along with 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grinter, SZ; Huang, SY; Hyder, SM; Liang, Y; Zou, X | 1 |
1 other study(ies) available for ro 48-8071 and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one
Article | Year |
---|---|
An inverse docking approach for identifying new potential anti-cancer targets.
Topics: Antineoplastic Agents; Aza Compounds; Benzophenones; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Computational Biology; DNA; Drug Discovery; Enzyme Inhibitors; Female; Humans; Intramolecular Transferases; Models, Molecular; Protein Binding; Protein Interaction Domains and Motifs; Tumor Suppressor Protein p53 | 2011 |